-
Forbes India 13th Anniversary: Rewind of Key Milestones of India's Corporates and Startups
A rewind of the key milestones in India's corporates and startups, through the lens of 13 years of Forbes India
Column
-
India has a fraught relationship with wealth
A lot has changed in India over the decades but not so much our attitude towards wealth and its creators. That is, until the startup boom made heroes out of unicorn makers
Billionaires
-
Dilip Shanghvi has built Sun Pharma by making bold bets. And he's not done yet
While others played safe, Shanghvi bet on complex generics and specialty pharma, and rode a wave of acquisitions to make Sun Pharma a global force. Now, as stakes rise, he is placing bigger and bolder bets
-
I'm determined. I'm not passionate: Dilip Shanghvi
Sun Pharma chairman and managing director Dilip Shanghvi reveals the secrets behind his leadership tenets of research and acquisition in an interview with Forbes India. He says his weight loss molecule, undergoing trials, can be a blockbuster
-
15 years and 3 unicorns: Will Bhavish Aggarwal's disruptive run continue?
Aggarwal made his debut on the Forbes World's Billionaires List this year with a personal wealth of $2 billion, almost a decade and a half since he first set out to build his own business
-
From CT Scans to MRIs: How Blue Jet Healthcare made it big with contrast media
Akshay Arora, chairman of Blue Jet Healthcare, has found and stuck to contrast media—a profitable and growing niche in the sector
-
Shalom Meckenzie: Betting big on at-home fitness
Shalom Meckenzie made a $1.4 billion fortune after merging his gambling software company with DraftKings. Now he's rolling the dice on Amp, an at-home exercise machine startup. It's a long-shot bet—but he has a good reason to make it
Leadership
-
Kailera: Betting on China's R&D for the next weight-loss miracle drug
It used to be that Chinese drug development was largely about creating "me too" drugs for the local market. But over the past 10 years, with Beijing focussed on building a native biotech industry, US-trained Chinese scientists have returned home and started innovating instead of mimicking
-
Virologist Michael Taylor volunteers help to cancer patients. His task: Picking health care stocks
Private businesses that give away all profits and also succeed as businesses are scarce; An eleemosynary aim would seem to be even more out of place on Wall Street, where "greed is good" is the mantra
From the Bookshelves
-
To challenge the status quo, you'll have to break some rules: Girish Mathrubootham
Girish Mathrubootham on life after stepping down as CEO of Freshworks, and the impact of the "monster wave" that is artificial intelligence on his business
